We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Barclays Plc | LSE:BARC | London | Ordinary Share | GB0031348658 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.85 | -1.16% | 242.25 | 242.15 | 242.25 | 245.05 | 240.60 | 244.80 | 61,010,354 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Commercial Banks, Nec | 25.38B | 5.26B | 0.3612 | 6.71 | 35.69B |
TIDMBARC
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader: BARCLAYS CAPITAL INC Company dealt in OSMOTICA PHARMACEUTICALS PLC Class of relevant security to which the US$0.01 ordinary shares dealings being disclosed relate Date of dealing 04 February 2021
2. INTERESTS AND SHORT POSITIONS
a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
Class of relevant security: ORD Interests Short Positions Number (%) Number (%) (1) Relevant securities owned 320 0.00% 0 0.00% (2) Derivatives (other than options): 0 0.00% 0 0.00% (3) Options and agreements to purchase/sell: 0 0.00% 0 0.00% TOTAL: 320 0.00% 0 0.00%
b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total
Ap28
3. DEALINGS (Note 3)
a. Purchases and sales
Purchase/sale Number of Price per unit securities Purchase 26 4.5200 USD Sale 26 4.5200 USD
b. Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per unit e.g. CFD (Note 5) securities (Note 6) (Note 4)
c. Options transactions in respect of existing relevant securities
i. Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option money name, selling, securities price e.g. date paid/received e.g. purchasing, to which American, per unit call varying the option European (Note 4) option etc. relates etc. (Note 7)
ii. Exercising
Product name, Number of securities Exercise price per unit (Note 4) e.g. call option
d. Other dealings (including transactions in respect of new securities) (Note 3)
Nature of transaction Details Price per unit (Note 7) (if applicable) (Note 4)
Ap29
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 38.5(b) attached? NO Date of disclosure: 05 Feb 2021 Contact name: Large Holdings Regulatory Operations Telephone number: 020 3134 7213 Name of offeree/offeror with which connected Nature of connection
View source version on businesswire.com: https://www.businesswire.com/news/home/20210205005209/en/
CONTACT:
BARCLAYS PLC
SOURCE: BARCLAYS PLC Copyright Business Wire 2021
(END) Dow Jones Newswires
February 05, 2021 06:05 ET (11:05 GMT)
1 Year Barclays Chart |
1 Month Barclays Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions